YBX3 and colorectal cancer: Loss of CLDN2 promotes the dissociation of the CLDN2/ZO1/ZONAB complex, which then induces ZONAB translocation to the nucleus and enrichment at the NDRG1 promotor to activate its transcription, thereby preventing the growth and spread of colorectal cancer (26, 86–91).